Sinemia Is Shutting Down in the U.S. Effective Immediately
The MoviePass competitor has sold its last ticket.
The MoviePass competitor has sold its last ticket.
While reports say that Sinemia might close, the company is lowering prices on too-good-to-be-true yearly plans as its service grows worse.
Business Insider reports the struggling company is down to just 225,000 subscribers.
“We knew what was sustainable. But the overriding voice was, ‘No, this is awesome, look how fast we’re growing,'” Stacy Spikes said in a rare interview.
In an extensive IndieWire interview Rifat Oguz responds to questions that have his customers boiling with anger.
As theaters struggle to appeal to moviegoers, movie ticket subscription services offer a new way to pull in moviegoers, though mileage continues to vary.
Sinemia was down this busy “Us” movie weekend, while it continued to cancel active members’ pre-paid yearly plans.
The movie ticket subscription wars get another contender, as Sinemia unveils its pricey version of MoviePass’ dead unlimited plan.